Loading
₹27.87
−3.06%BSE close, 16 Nov 2026
+21.23%
UNJHA FORMULATIONS is a small cap company in the Healthcare sector, listed on BSE under the symbol UNJHAFOR (BSE code 531762). At ₹27.87 a share, the market values the whole company at ₹12 crore.
Over the past year the share price has risen 21.2%, and it is 23.4% below its 52-week high.
Companies of a similar size in the same sector include VENMAX DRUGS AND PHARMACEUTICA, Global Longlife Hospital and R, STARSOURCE MULTITRADE and DESH RAKSHAK AUSHDHALAYA.
This company is listed only on BSE, so its page shows price figures only: results and shareholding on RupeeVerse come from companies’ NSE filings.
The same sector (Healthcare), nearest in size.
| Company | Price | Market cap | P/E | ROE | Sales growth | 1Y |
|---|---|---|---|---|---|---|
| UNJHA FORMULATIONS | ₹27.87 | ₹12 cr | n/a | n/a | n/a | +21.23% |
| VENMAX DRUGS AND PHARMACEUTICA | ₹12.36 | ₹14 cr | n/a | n/a | n/a | −55.60% |
| Global Longlife Hospital and R | ₹13.53 | ₹14 cr | n/a | n/a | n/a | −42.96% |
| STARSOURCE MULTITRADE | ₹91.75 | ₹14 cr | n/a | n/a | n/a | −22.28% |
| DESH RAKSHAK AUSHDHALAYA | ₹23.50 | ₹13 cr | n/a | n/a |
| n/a |
| −34.17% |
| Vanta Bioscience | ₹18.50 | ₹13 cr | n/a | n/a | n/a | −33.19% |
|---|
| BERYL DRUGS | ₹24.59 | ₹12 cr | n/a | n/a | n/a | +6.45% |
|---|
| DOLPHIN MEDICAL SERVICES | ₹7.83 | ₹12 cr | n/a | n/a | n/a | +274.64% |
|---|
| DIPNA PHARMACHEM | ₹4.22 | ₹11 cr | n/a | n/a | n/a | −77.97% |
|---|